Overview
Dr. Om Shrivastav is a Consultant in Infectious diseases and Immunology at Sir H. N. Reliance Foundation Hospital and Research Centre. He has completed his training in M.D. (Medicine) from India. He then commenced his training in Sydney, Australia where he trained at St. Vincent’s Hospital, Liverpool Hospital & Royal North Shore Hospital. He was the Principal Investigator, RALTEGRAVIR - newest group of drug in treatment of HIV, approved for use in 2010. Jaslok Hospital Mumbai was selected for trial and was concluded successfully after five years.
Specialties
- Primary Care Physician
Condition Treated
- Piles Treatment (Non Surgical)
- Gestational Diabetes Management
- Type 2 Diabetes Treatment
- Diabetes Management
- Viral Fever Treatment
- Bronchial Asthma Treatment
- Rheumatologic Disorders
- Neuropsychiatric Disorders
- Metabolic Disorders
- Hematology/Oncology
- Gastrointestinal Diseases
- Cardiovascular Diseases
- Wound Healing
- Trunk
- Skin
- Rhytidectomy
- Nose
- Lower Extremity Reconstruction
- Infections
- Head and Neck
- Hand
- Flaps
- Facial Fractures
- Facial Augmentation
- Eyelids
- Craniofacial
- Burns
- Breast
- Body Contouring
- Ancillary Procedures
- Upper Limb Musculoskeletal Conditions
- Traumatic Brain Injury
- Therapeutic Modalities
- Stroke
- Spinal Cord Injury
- Rehabilitation Protocols
- Plexopathy
- Peripheral Neuropathy
- Occupational Medicine
- Myopathy
- Muscular Dystrophy
- Muscle Pain Syndromes
- Movement Disorders
- Medical Diseases
- Lumbar Spine Disorders
- Lower Limb Musculoskeletal Conditions
- Disorders Of The Motor Unit
- Cervical Spine Disorders
- Arthritis And Connective Tissue Disorders
- Jaundice Treatment
- Joint and Muscle Problems
- Migraine Treatment
- Thyroid Disease in Children
- Type 1 Diabetes Treatment
Education and Training
-
RESIDENCY
MD -
MEDICAL SCHOOL
MBBS
Clinic Visit Time
Overview
26 years
Dr. Om Shrivastav is a Consultant in Infectious diseases and Immunology at Sir H. N. Reliance Foundation Hospital and Research Centre. He has completed his training in M.D. (Medicine) from India. He then commenced his training in Sydney, Australia where he trained at St. Vincent’s Hospital, Liverpool Hospital & Royal North Shore Hospital. He was the Principal Investigator, RALTEGRAVIR - newest group of drug in treatment of HIV, approved for use in 2010. Jaslok Hospital Mumbai was selected for trial and was concluded successfully after five years.
Conditioned Treated
- Piles Treatment (Non Surgical)
- Gestational Diabetes Management
- Type 2 Diabetes Treatment
- Diabetes Management
- Viral Fever Treatment
- Bronchial Asthma Treatment
- Rheumatologic Disorders
- Neuropsychiatric Disorders
- Metabolic Disorders
- Hematology/Oncology
- Gastrointestinal Diseases
- Cardiovascular Diseases
- Wound Healing
- Trunk
- Skin
- Rhytidectomy
- Nose
- Lower Extremity Reconstruction
- Infections
- Head and Neck
- Hand
- Flaps
- Facial Fractures
- Facial Augmentation
- Eyelids
- Craniofacial
- Burns
- Breast
- Body Contouring
- Ancillary Procedures
- Upper Limb Musculoskeletal Conditions
- Traumatic Brain Injury
- Therapeutic Modalities
- Stroke
- Spinal Cord Injury
- Rehabilitation Protocols
- Plexopathy
- Peripheral Neuropathy
- Occupational Medicine
- Myopathy
- Muscular Dystrophy
- Muscle Pain Syndromes
- Movement Disorders
- Medical Diseases
- Lumbar Spine Disorders
- Lower Limb Musculoskeletal Conditions
- Disorders Of The Motor Unit
- Cervical Spine Disorders
- Arthritis And Connective Tissue Disorders
- Jaundice Treatment
- Joint and Muscle Problems
- Migraine Treatment
- Thyroid Disease in Children
- Type 1 Diabetes Treatment
Specialties
- Primary Care Physician
Education and Training
-
RESIDENCY
MD -
MEDICAL SCHOOL
MBBS
PHYSICIAN RATING
CLINIC RATING
Location
1, Lok Bharti Rd, Gamdevi, Marol,,Andheri East, Mumbai, Andheri East, Mumbai-400059, Maharashtra, India